Recognition of human proinsulin leader sequence by class I-restricted T-cells in HLA-A*0201 transgenic mice and in human type 1 diabetes

Diabetes

Volumn 58, Issue 2, 2009, Pages 394-402

  Toma, Andréa ^a   Laïka, Taghrid ^a,b   Haddouk, Samy ^a   Luce, Sandrine ^a   Briand, Jean Paul ^c   Camoin, Luc ^d   Connan, Francine ^d   Lambert, Marion ^a   Caillat Zucman, Sophie ^a   Carel, Jean Claude ^a   Muller, Sylviane ^c   Choppin, Jeannine ^d   Lemonnier, François ^b   Boitard, Christian ^a,e  

^a INSERM   (France)

^b INSTITUT PASTEUR   (France)

^c CNRS   (France)

^d UNIVERSITÉ PARIS DESCARTES   (France)

^e NONE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

HLA A ANTIGEN; HLA A1 ANTIGEN; HLA A2 ANTIGEN; HLA A24 ANTIGEN; HLA B ANTIGEN; PREPROINSULIN; PROINSULIN; SIGNAL PEPTIDE; EPITOPE; HLA ANTIGEN; PEPTIDE FRAGMENT; PROTEASOME;

ANIMAL CELL; ANTIGEN RECOGNITION; ARTICLE; AUTOIMMUNITY; CARBOXY TERMINAL SEQUENCE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOPATHOGENESIS; INSULIN DEPENDENT DIABETES MELLITUS; MOUSE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; TRANSGENIC MOUSE; ANIMAL; CELL LINE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENETICS; IMMUNOLOGY; MALE; METABOLISM;

ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; CELL LINE; DIABETES MELLITUS, TYPE 1; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPES; FEMALE; HLA ANTIGENS; HUMANS; MALE; MICE; MICE, TRANSGENIC; PEPTIDE FRAGMENTS; PROINSULIN; PROTEASOME ENDOPEPTIDASE COMPLEX;

EID: 63249123615     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db08-0599     Document Type: Article

References (49)

1. Martin S, Wolf-Eichbaum D, Duinkerken G, Scherbaum WA, Kolb H, Noordzij JG, Roep BO: Development of type 1 diabetes despite severe hereditary B-lymphocyte deficiency. N Engl J Med 345:1036-1040, 2001
2. Verdaguer J, Schmidt D, Amrani A, Anderson B, Averill N, Santamaria P: Spontaneous autoimmune diabetes in monoclonal T cell nonobese diabetic mice. J Exp Med 186:1663-1676, 1997
3. Itoh N, Hanafusa T, Miyazaki A, Miyagawa J, Yamagata K, Yamamoto K, Waguri M, Imagawa A, Tamura S, Inada M, Kawata S, Tarui S, Kono N, Matsuzawa Y: Mononuclear cell infiltration and its relation to the expression of major histocompatibility complex antigens and adhesion molecules in pancreas biopsy specimens from newly diagnosed insulin-dependent diabetes mellitus patients. J Clin Invest 92:2313-2322, 1993
4. Somoza N, Vargas F, Roura-Mir C, Vives-Pi M, Fernandez-Figueras MT, Ariza A, Gomis R, Bragado R, Marti M, Jaraquemada D: Pancreas in recent onset insulin-dependent diabetes mellitus: changes in HLA, adhesion molecules and autoantigens, restricted T cell receptor V. J Immunol 153:1360-1377, 1994
5. Conrad B, Weidmann E, Trucco G, Rudert WA, Behboo R, Ricordi C, Rodriquez-Rilo H, Finegold D, Trucco M: Evidence for superantigen involvement in insulin-dependent diabetes mellitus aetiology. Nature 371:351-355, 1994
6. Foulis AK, McGill M, Farquharson MA: Insulitis in type 1 (insulin- dependent) diabetes mellitus in man: macrophages, lymphocytes, and interferon-gamma containing cells. J Pathol 165:97-103, 1991
7. Sibley RK, Sutherland DE, Goetz F, Michael AF: Recurrent diabetes mellitus in the pancreas iso- and allograft: a light and electron microscopic and immunohistochemical analysis of four cases. Lab Invest 53:132-144, 1985
8. Yu L, Robles DT, Abiru N, Kaur P, Rewers M, Kelemen K, Eisenbarth GS: Early expression of antiinsulin autoantibodies of humans and the NOD mouse: evidence for early determination of subsequent diabetes. Proc NatlAcad Sci USA 97:1701-1706, 2000
9. Ziegler AG, Hummel M, Schenker M, Bonifacio E: Autoantibody appearance and risk for development of childhood diabetes in offspring ofparents with type 1 diabetes: the 2-year analysis of the German BABYDIAB Study. Diabetes 48:460-468, 1999
10. Keller RJ: Cellular immunity to human insulin in individuals at high risk for the development of type I diabetes mellitus. JAutoimmun 3:321-327, 1990
11. Schloot NC, Roep BO, Wegmann D, Yu L, Chase HP, Wang T, Eisenbarth GS: Altered immune response to insulin in newly diagnosed compared to insulin-treated diabetic patients and healthy control subjects. Diabetologia 40:564-572, 1997
12. Rudy G, Stone N, Harrison LC, Colman PG, McNair P, Brusic V, French MB, Honeyman MC, Tait B, Lew AM: Similar peptides from two beta cell autoantigens, proinsulin and glutamic acid decarboxylase, stimulate T cells of individuals at risk for insulin-dependent diabetes. Mol Med 1:625-633, 1995
13. Dubois-LaForgue D, Carel JC, Bougneres PF, Guillet JG, Boitard C: T-cell response to proinsulin and insulin in type 1 and pretype 1 diabetes. J Clin Immunol 19:127-134, 1999
14. Alleva DG, Crowe PD, Jin L, Kwok WW, Ling N, Gottschalk M, Conlon PJ, Gottlieb PA, Putnam AL, Gaur A: A disease-associated cellular immune response in type 1 diabetics to an immunodominant epitope of insulin. J Clin Invest 107:173-180, 2001
15. Petersen LD, Duinkerken G, Bruining GJ, van Lier RA, de Vries RR, Roep BO: Increased numbers of in vivo activated T cells in patients with recent onset insulin-dependent diabetes mellitus. J Autoimmun 9:731-737, 1996
16. Durinovic-Bello I, Schlosser M, Riedl M, Maisel N, Rosinger S, Kalbacher H, Deeg M, Ziegler M, Elliott J, Roep BO, Karges W, Boehm BO: Pro- and anti-inflammatory cytokine production by autoimmune T cells against preproinsulin in HLA-DRB1*04, DQ8 type 1 diabetes. Diabetologia 47:439450, 2004
17. Naquet P, Ellis J, Tibensky D, Kenshole A, Singh B, Hodges R, Delovitch TL: T cell autoreactivity to insulin in diabetic and related non-diabetic individuals. J Immunol 140:2569-2578, 1988
18. Daniel D, Gill RG, Schloot N, Wegmann D: Epitope specificity, cytokine production profile and diabetogenic activity of insulin-specific T cell clones isolated from NOD mice. Eur J Immunol 25:1056-1062, 1995
19. Daniel D, Wegmann DR: Protection of nonobese diabetic mice from diabetes by intranasal or subcutaneous administration of insulin peptide B-(9 -23). Proc Natl Acad SciUSA93:956-960, 1996
20. Thebault-Baumont K, Dubois-Laforgue D, Krief P, Briand JP, Halbout P, Vallon-Geoffroy K, Morin J, Laloux V, Lehuen A, Carel JC, Jami J, Muller S, Boitard C: Acceleration of type 1 diabetes mellitus in proinsulin 2-deficient NOD mice. J Clin Invest 111:851-857, 2003
21. Moriyama H, Abiru N, Paronen J, Sikora K, Liu E, Miao D, Devendra D, Beilke J, Gianani R, Gill RG, Eisenbarth GS: Evidence for a primary islet autoantigen (preproinsulin 1) for insulitis and diabetes in the nonobese diabetic mouse. Proc Natl Acad SciUSA100:10376-10381, 2003
22. Hassainya Y, Garcia-Pons F, Kratzer R, Lindo V, Greer F, Lemonnier FA, Niedermann G, van Endert PM: Identification of naturally processed HLA-A2-restricted proinsulin epitopes by reverse immunology. Diabetes 54:2053-2059, 2005
23. Toma A, Haddouk S, Briand JP, Camoin L, Gahery H, Connan F, Dubois- Laforgue D, Caillat-Zucman S, Guillet JG, Carel JC, Muller S, Choppin J, Boitard C: Recognition of a subregion of human proinsulin by class I-restricted T cells in type 1 diabetic patients. Proc Natl Acad SciUSA 102:10581-10586, 2005
24. Jarchum I, Nichol L, Trucco M, Santamaria P, DiLorenzo TP: Identification of novel IGRP epitopes targeted in type 1 diabetes patients. Clin Immunol 127:359-365, 2008
25. Baker C, Petrich de Marquesini LG, Bishop AJ, Hedges AJ, Dayan CM, Wong FS: Human CD8 responses to a complete epitope set from prepro- insulin: implications for approaches to epitope discovery. J Clin Immunol 28:350-360, 2008
26. + T-cell responses identify β-cell autoimmunity in human type 1 diabetes. Diabetes 56:613621, 2007
27. + T-cell responses change after type 1 diabetes diagnosis and treatment. Diabetes 57:1312-1320, 2008
28. Henderson RA, Michel H, Sakaguchi K, Shabanowitz J, Appella E, Hunt DF, Engelhard VH: HLA-A2.1-associated peptides from a mutant cell line: a second pathway of antigen presentation. Science 255:1264-1266, 1992
29. Pascolo S, Bervas N, Ure JM, Smith AG, Lemonnier FA, Perarnau B: HLA-A2.1-restricted education and cytolytic activity of CD8(+) T lymphocytes from beta2 microglobulin (beta2m) HLA-A2.1 monochain transgenic H-2Db beta2m double knockout mice. J Exp Med 185:2043-2051, 1997
30. Choppin J, Cohen W, Bianco A, Briand JP, Connan F, Dalod M, Guillet JG: Characteristics of HIV-1 Nef regions containing multiple CD8+ T cell epitopes: wealth of HLA-binding motifs and sensitivity to proteasome degradation. J Immunol 166:6164-6169, 2001
31. Altman JD, Moss PA, Goulder PJ, Barouch DH, McHeyzer-Williams MG, Bell JI, McMichael AJ, Davis MM: Phenotypic analysis of antigen-specific T lymphocytes. Science 274:94-96, 1996
32. Raju R, Munn SR, David CS: T cell recognition of human pre-proinsulin peptides depends on the polymorphism at HLA DQ locus: a study using HLA DQ8 and DQ6 transgenic mice. Hum, Immunol 58:21-29, 1997
33. Endl J, Otto H, Jung G, Dreisbusch B, Donie F, Stahl P, Elbracht R, Schmitz G, Meinl E, Hummel M, Ziegler AG, Wank R, Schendel DJ: Identification of naturally processed T cell epitopes from glutamic acid decarboxylase presented in the context of HLA-DR alleles by T lymphocytes of recent onset IDDM patients. J Clin Invest 99:2405-2415, 1997
34. Herman AE, Tisch RM, Patel SD, Parry SL, Olson J, Noble JA, Cope AP, Cox B, Congia M, McDevitt HO: Determination of glutamic acid decarbox- ylase 65 peptides presented by the type I diabetes-associated HLA-DQ8 class II molecule identifies an immunogenic peptide motif. J Immunol 163:6275-6282, 1999
35. Panina-Bordignon P, Lang R, van Endert PM, Benazzi E, Felix AM, Pastore RM, Spinas GA, Sinigaglia F: Cytotoxic T cells specific for glutamic acid decarboxylase in autoimmune diabetes. J Exp Med 181:1923-1927, 1995
36. Panagiotopoulos C, Qin H, Tan R, Verchere CB: Identification of a β-cell-specific HLA class I restricted epitope in type 1 diabetes. Diabetes 52:2647-2651, 2003
37. Ouyang Q, Standifer NE, Qin H, Gottlieb P, Verchere CB, Nepom GT, Tan R, Panagiotopoulos C: Recognition of HLA class I-restricted p-cell epitopes in type 1 diabetes. Diabetes 55:3068-3074, 2006
38. Standifer NE, Ouyang Q, Panagiotopoulos C, Verchere CB, Tan R, Green- baum CJ, Pihoker C, Nepom GT: Identification of novel HLA-A*0201- restricted epitopes in recent-onset type 1 diabetic subjects and antibody- positive relatives. Diabetes 55:3061-3067, 2006
39. Pinkse GG, Boitard C, Tree TI, Peakman M, Roep BO: HLA class I epitope discovery in type 1 diabetes: independent and reproducible identification of proinsulin epitopes of CD8 T cells: report of the IDS T Cell Workshop Committee. Ann N Y Acad Sci 1079:19-23, 2006
40. van Endert P, Hassainya Y, Lindo V, Bach JM, Blancou P, Lemonnier F, Mallone R: HLA class I epitope discovery in type 1 diabetes. Ann NY Acad Sci 1079:190-197, 2006
41. Pinkse GG, Tysma OH, Bergen CA, Kester MG, Ossendorp F, van Veelen PA, Keymeulen B, Pipeleers D, Drijfhout JW, Roep BO: Autoreactive CD8 T cells associated with beta cell destruction in type 1 diabetes. Proc Natl Acad Sci USA 102:18425-18430, 2005
42. Gueguen M, Biddison WE, Long EO: T cell recognition of an HLA-A2- restricted epitope derived from a cleaved signal sequence. J Exp Med 180:1989-1994, 1994
43. Chen W, Bergerot I, Elliott JF, Harrison LC, Abiru N, Eisenbarth GS, Delovitch TL: Evidence that a peptide spanning the B-C junction of proinsulin is an early Autoantigen epitope in the pathogenesis of type 1 diabetes. J Immunol 167:4926-4935, 2001
44. Chang L, Kjer-Nielsen L, Flynn S, Brooks AG, Mannering SI, Honeyman MC, Harrison LC, McCluskey J, Purcell AW: Novel strategy for identification of candidate cytotoxic T-cell epitopes from human preproinsulin. Tissue Antigens 62:408-417, 2003
45. Kessler JH, Beekman NJ, Bres-Vloemans SA, Verdijk P, van Veelen PA, Kloosterman-Joosten AM, Vissers DC, ten Bosch GJ, Kester MG, Sijts A, Drijfhout JW, Ossendorp F, Offringa R, Melief CJ: Efficient identification of novel HLA-A(*)0201-presented cytotoxic T lymphocyte epitopes in the widely expressed tumor antigen PRAME by proteasome-mediated digestion analysis. J Exp Med 193:73-88, 2001
46. Kloetzel PM: Generation of major histocompatibility complex class I antigens: functional interplay between proteasomes and TPPII. Nat Immunol 5:661-669, 2004
47. Engelhard VH, Brickner AG, Zarling AL: Insights into antigen processing gined by direct analysis of the naturally processed class I MHC associated peptide repertoire. Mol Immunol 39:127-137, 2002
48. Yewdell JW: Confronting complexity: real-world immunodominance in antiviral CD8 + T cell responses. Immunity 25:533-543, 2006
49. Berthelot L, Laplaud DA, Pettré S, Ballet C, Michel L, Hillion S, Braudeau C, Connan F, Lefrère F, Wiertlewski S, Guillet JG, Brouard S, Choppin J, Soulillou JP: Blood CD8(+ ) T cell responses against myelin determinants in multiple sclerosis and healthy individuals. Eur J Immunol 38:18891899, 2008